We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Illumina Inc | NASDAQ:ILMN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.23 | 1.02% | 122.28 | 121.50 | 123.70 | 123.73 | 118.97 | 119.65 | 829,331 | 21:00:10 |
From Apr 2019 to Apr 2024
Illumina Inc. (ILMN) fell back 7.8% in premarket trading Monday after Roche Holding (RHHBY) Chairman Franz Humer said in an interview that the company doesn't plan to buy the gene sequencing specialist.
"Illumina is definitely off the table," Humer said in an interview published Sunday. Shares of Illumina fell to $50.50 in recent premarket trading. Roche had approached Illumina with a buyout offer of $6.8 billion last year, but the company was rebuffed.
-Write to Steve Gelsi at sgelsi@marketwatch.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Illumina Chart |
1 Month Illumina Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
